We have located links that may give you full text access.
Metabolic and bone profile in postmenopausal women with and without type 2 diabetes: a cross-sectional study.
Romanian Journal of Internal Medicine 2018 November 16
INTRODUCTION: Current studies support the implication of metabolic changes associated with type 2 diabetes in altering bone metabolism, structure and resistance.
OBJECTIVE: We conducted a cross-sectional study on postmenopausal women aimed to analyze the differences in metabolic and bone profile in patients with and without type 2 diabetes Methods: We analyzed the metabolic and bone profile in postmenopausal women with and without type 2 diabetes(T2DM). Clinical, metabolic, hormonal parameters, along with lumbar, hip and femoral bone mineral density (BMD) and trabecular bone score (TBS) were evaluated.
RESULTS: 56 women with T2DM(63.57±8.97 years) and 83 non-T2DM (60.21±8.77 years) were included. T2DM patients presented a higher value of body mass index (BMI) and BMD vs. control group (p 0.001; p=0.03-lumbar level, p=0.07-femoral neck and p=0.001-total hip). Also, BMI correlated positively with lumbar-BMD and glycated hemoglobin (HbA1c) (r=0.348, p=0.01; r=0.269, p=0.04), correlation maintained even after age and estimated glomerular filtration rate (eGFR) adjustment (r = 0.383, p = 0.005; r=0.237, p=0.08). Diabetic patients recorded lower levels of 25(OH)D(p=0.05), bone markers (p ≤0.05) and TBS(p=0.07). For the entire patient group we found a negative correlation between HbA1clevel and bone markers: r =-0.358, p = 0.0005-osteocalcin, r =-0.40, p = 0.0005-P1NP, r =-0.258, p = 0.005-crosslaps.
CONCLUSIONS: Our results indicate the presence of altered bone microarchitecture in T2DZ patients according to the TBS score, combined with lower levels of bone markers, with a statistically significant negative correlation between HbA1c level and bone markers.
OBJECTIVE: We conducted a cross-sectional study on postmenopausal women aimed to analyze the differences in metabolic and bone profile in patients with and without type 2 diabetes Methods: We analyzed the metabolic and bone profile in postmenopausal women with and without type 2 diabetes(T2DM). Clinical, metabolic, hormonal parameters, along with lumbar, hip and femoral bone mineral density (BMD) and trabecular bone score (TBS) were evaluated.
RESULTS: 56 women with T2DM(63.57±8.97 years) and 83 non-T2DM (60.21±8.77 years) were included. T2DM patients presented a higher value of body mass index (BMI) and BMD vs. control group (p 0.001; p=0.03-lumbar level, p=0.07-femoral neck and p=0.001-total hip). Also, BMI correlated positively with lumbar-BMD and glycated hemoglobin (HbA1c) (r=0.348, p=0.01; r=0.269, p=0.04), correlation maintained even after age and estimated glomerular filtration rate (eGFR) adjustment (r = 0.383, p = 0.005; r=0.237, p=0.08). Diabetic patients recorded lower levels of 25(OH)D(p=0.05), bone markers (p ≤0.05) and TBS(p=0.07). For the entire patient group we found a negative correlation between HbA1clevel and bone markers: r =-0.358, p = 0.0005-osteocalcin, r =-0.40, p = 0.0005-P1NP, r =-0.258, p = 0.005-crosslaps.
CONCLUSIONS: Our results indicate the presence of altered bone microarchitecture in T2DZ patients according to the TBS score, combined with lower levels of bone markers, with a statistically significant negative correlation between HbA1c level and bone markers.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app